Cash flow Imeik Technology Development Co.,Ltd.

Equities

300896

CNE100004868

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 11/03/2026			5-day change	1st Jan Change
143.68 ^CNY	+2.23%		+3.26%	+1.38%

01-09	Imeik Technology Development Gets Approval for Botox Injection; Shares Up 3%	MT
11-14	Imeik Technology Development Co.,Ltd. Announces Directorate Appointments	CI

a990bd61.J1XVaNpWjeasSy7RMJ3bemJCnBe1krO8HWpqZqvjz6I.Tw-_N5g4wr6BIB3kW_6_MFNz1WGG1saMbShTXsPUtpEXZqVQnjfZvskbWQ

Published financial data: IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	709M	1.45B	1.94B	2.87B	3.03B
Other Revenues, Total	-	-	-	-	297K
Total Revenues	709M	1.45B	1.94B	2.87B	3.03B
Cost of Goods Sold, Total	55.53M	91.28M	99.91M	141M	162M
Gross Profit	654M	1.36B	1.84B	2.73B	2.86B
Selling General & Admin Expenses, Total	117M	221M	288M	405M	400M
Provision for Bad Debts	849K	-	-	4.12M	-1.88M
R&D Expenses	61.8M	102M	173M	250M	304M
Other Operating Expenses	3.66M	6.66M	9.5M	15.37M	18.55M
Other Operating Expenses, Total	183M	330M	471M	674M	720M
Operating Income	470M	1.03B	1.37B	2.05B	2.14B
Interest Expense, Total	-	-2.14M	-3.15M	-2.38M	-2.55M
Interest And Investment Income	29.13M	72.69M	81.81M	97.91M	99.7M
Net Interest Expenses	29.13M	70.55M	78.66M	95.53M	97.15M
Currency Exchange Gains (Loss)	-	-	-	-833K	300K
Other Non Operating Income (Expenses)	-62.96K	-2.72M	-2.96M	-1.23M	18.6K
EBT, Excl. Unusual Items	499M	1.09B	1.44B	2.15B	2.24B
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	1.57M	27.37M	29.41M	-16.08M	33.16M
Gain (Loss) On Sale Of Assets	-2.52K	-12.62K	144	14.53K	71.59K
Asset Writedown	-143K	-34.01K	-143K	-121K	-4.25K
Other Unusual Items	1.77M	270K	15.14M	23.9M	6.83M
EBT, Incl. Unusual Items	503M	1.12B	1.49B	2.16B	2.28B
Income Tax Expense	69.27M	165M	221M	301M	325M
Earnings From Continuing Operations	433M	957M	1.27B	1.85B	1.96B
Net Income to Company	433M	957M	1.27B	1.85B	1.96B
Minority Interest	6.36M	465K	-4.03M	3.56M	1.26M
Net Income - (IS)	440M	958M	1.26B	1.86B	1.96B
Net Income to Common Incl Extra Items	440M	958M	1.26B	1.86B	1.96B
Net Income to Common Excl. Extra Items	440M	958M	1.26B	1.86B	1.96B
Per Share Items
Net EPS - Basic	1.79	3.16	4.17	6.14	6.5
Basic EPS - Continuing Operations	1.79	3.16	4.17	6.14	6.5
Basic Weighted Average Shares Outstanding	246M	303M	303M	303M	301M
Net EPS - Diluted	1.79	3.16	4.17	6.14	6.5
Diluted EPS - Continuing Operations	1.79	3.16	4.17	6.14	6.5
Diluted Weighted Average Shares Outstanding	246M	303M	303M	303M	301M
Normalized Basic EPS	1.3	2.26	2.97	4.45	4.65
Normalized Diluted EPS	1.3	2.26	2.97	4.45	4.65
Dividend Per Share	1.39	1.5	2	2.98	3.8
Payout Ratio	-	43.92	35.96	54.06	25.54
Supplemental Items
EBITDA	481M	1.04B	1.38B	2.08B	2.17B
EBITA	471M	1.03B	1.37B	2.06B	2.15B
EBIT	470M	1.03B	1.37B	2.05B	2.14B
EBITDAR	481M	1.04B	1.38B	2.09B	2.18B
Total Revenues (As Reported)	709M	1.45B	1.94B	2.87B	3.03B
Effective Tax Rate - (Ratio)	13.78	14.66	14.83	13.95	14.23
Current Domestic Taxes	-	159M	206M	317M	-
Total Current Taxes	69.1M	159M	206M	317M	321M
Deferred Domestic Taxes	-	5.26M	14.45M	-16.47M	-
Total Deferred Taxes	169K	5.26M	14.45M	-16.47M	4.13M
Normalized Net Income	319M	684M	898M	1.35B	1.4B
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	-	2.14M	3.15M	2.38M	2.55M
Non-Cash Pension Expense	-	-	-	-	331K
Supplemental Operating Expense Items
Advertising Expense	4.14M	12.53M	21.2M	26.74M	24.08M
Selling and Marketing Expenses	73.56M	156M	163M	260M	277M
General and Administrative Expenses	43.5M	64.72M	125M	144M	123M
Research And Development Expense From Footnotes	61.8M	102M	173M	250M	304M
Net Rental Expense, Total	184K	184K	184K	4.86M	5.81M
Imputed Operating Lease Interest Expense	-	-	86.17K	1.65M	2.43M
Imputed Operating Lease Depreciation	-	-	98.3K	3.21M	3.38M
Stock-Based Comp., Other (Total)	-	-	-	47M	-14.86M
Total Stock-Based Compensation	-	-	-	47M	-14.86M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	3.46B	3.26B	3.14B	2.43B	1.51B
Short Term Investments	-	-	80M	299M	345M
Trading Asset Securities, Total	842M	371M	704M	1.2B	2.88B
Total Cash And Short Term Investments	4.3B	3.63B	3.92B	3.94B	4.74B
Accounts Receivable, Total	29.82M	72.35M	128M	206M	168M
Other Receivables	15.53M	9.69M	4.6M	12.03M	7.77M
Total Receivables	45.35M	82.04M	132M	218M	176M
Inventory	26.8M	34.94M	46.72M	49.77M	72.84M
Other Current Assets, Total	6.27M	52.22M	31.38M	46.2M	58.71M
Total Current Assets	4.38B	3.8B	4.13B	4.25B	5.05B
Gross Property Plant And Equipment	176M	241M	382M	442M	720M
Accumulated Depreciation	-32.77M	-50.88M	-124M	-160M	-198M
Net Property Plant And Equipment	143M	190M	258M	282M	521M
Long-term Investments	58.89M	1.21B	1.41B	1.86B	2.28B
Goodwill	-	-	245M	245M	278M
Other Intangibles, Total	10.36M	11.99M	117M	115M	110M
Deferred Tax Assets Long-Term	1.79M	2.37M	8.48M	17.72M	7.23M
Deferred Charges Long-Term	8.21M	9.64M	39M	35.28M	34.91M
Other Long-Term Assets, Total	34.7M	34.25M	49.52M	46.54M	63.85M
Total Assets	4.63B	5.26B	6.26B	6.85B	8.34B
Liabilities
Accounts Payable, Total	4.56M	8.55M	19.34M	44.7M	82.99M
Accrued Expenses, Total	32.92M	104M	82.49M	115M	121M
Short-term Borrowings	-	-	-	-	-
Current Portion of Leases	-	7.94M	11.3M	15M	18.94M
Current Income Taxes Payable	20.86M	36.43M	9.61M	39.58M	608K
Unearned Revenue Current, Total	17.22M	12.74M	14.71M	50.63M	84.56M
Other Current Liabilities	13.65M	8.78M	86.72M	32.97M	36.13M
Total Current Liabilities	89.21M	179M	224M	298M	344M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	-	40.19M	48.39M	37.46M	26.01M
Unearned Revenue Non Current	9.77M	8.09M	4.15M	3.37M	2.35M
Deferred Tax Liability Non Current	2.47M	8.31M	36.06M	28.82M	18.09M
Total Liabilities	101M	235M	313M	367M	390M
Common Stock, Total	120M	216M	216M	216M	303M
Additional Paid In Capital	3.54B	3.41B	3.41B	3.46B	3.39B
Retained Earnings	869M	1.41B	2.22B	3.07B	4.53B
Treasury Stock	-	-	-	-400M	-400M
Comprehensive Income and Other	-	-3.69M	2.81M	2.87M	-22.39M
Total Common Equity	4.53B	5.03B	5.85B	6.35B	7.8B
Minority Interest	-2.59M	178K	99.65M	137M	153M
Total Equity	4.53B	5.03B	5.95B	6.49B	7.95B
Total Liabilities And Equity	4.63B	5.26B	6.26B	6.85B	8.34B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	303M	303M	303M	301M	301M
ECS Total Common Shares Outstanding	303M	303M	303M	301M	301M
Book Value / Share	14.97	16.6	19.3	21.07	25.87
Tangible Book Value	4.52B	5.02B	5.48B	5.99B	7.41B
Tangible Book Value Per Share	14.93	16.56	18.11	19.88	24.58
Total Debt	0	48.12M	59.69M	52.46M	44.96M
Net Debt	-4.3B	-3.59B	-3.86B	-3.88B	-4.69B
Debt Equivalent Oper. Leases	1.48M	1.48M	1.48M	38.91M	46.47M
Minority Interest, Total (Incl. Fin. Div)	-2.59M	178K	99.65M	137M	153M
Equity Method Investments, Total	33.89M	1B	935M	951M	918M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	10.65M	16.66M	21.14M	19.2M	26.89M
Inventories - Work In Process, Total	4.81M	5.31M	5.01M	8.53M	13.32M
Inventories - Finished Goods, Total	11.65M	13.15M	20.66M	22.13M	32.64M
Buildings, Total	120M	119M	185M	205M	205M
Machinery, Total	55.94M	66.97M	113M	138M	180M
Full Time Employees	388	507	713	910	1.22K
Accumulated Allowance for Doubtful Accounts (Supple)	1.57M	3.81M	6.77M	10.85M	8.98M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	440M	958M	1.26B	1.86B	1.96B
Depreciation & Amortization - CF	10.49M	18.15M	25.57M	36.56M	40.77M
Amortization of Goodwill and Intangible Assets - (CF)	201K	201K	201K	7.04M	3.01M
Depreciation & Amortization, Total	10.69M	18.35M	25.77M	43.6M	43.78M
Amortization of Deferred Charges, Total - (CF)	382K	1.36M	2.86M	9.01M	11.26M
(Gain) Loss From Sale Of Asset	2.52K	12.62K	-144	-14.53K	-71.59K
(Gain) Loss on Sale of Investments - (CF)	-14.73M	-18.48M	-62.54M	-23.59M	-99.01M
Asset Writedown & Restructuring Costs	-562K	-24.75M	2.79M	4.63M	4.25K
Provision and Write-off of Bad Debts	-	-	-	-	-1.88M
Other Operating Activities, Total	-6.36M	1.67M	7.17M	-1.22M	972K
Change In Accounts Receivable	-9.57M	-60.5M	-25.2M	-103M	50.95M
Change In Inventories	-3.4M	-8.14M	-5.61M	-3.06M	-16.45M
Change In Accounts Payable	9.31M	70.2M	-29.31M	138M	-8.91M
Change In Deferred Taxes	169K	5.26M	14.45M	-16.47M	4.13M
Change in Other Net Operating Assets	-	-	-	47M	-15.2M
Cash from Operations	426M	943M	1.19B	1.95B	1.93B
Capital Expenditure	-32.11M	-23.03M	-156M	-63.68M	-239M
Sale of Property, Plant, and Equipment	14.26K	6.84K	2.59K	21.88K	19.21K
Cash Acquisitions	-	-	-239M	-70M	-5.17M
Investment in Marketable and Equity Securities, Total	-899M	-652M	-574M	-1.17B	-2.15B
Other Investing Activities, Total	15.14M	26.77M	24.65M	27.46M	35.5M
Cash from Investing	-916M	-648M	-944M	-1.28B	-2.36B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-	-8.75M	-15.27M	-15.46M	-20.42M
Total Debt Repaid	-	-8.75M	-15.27M	-15.46M	-20.42M
Issuance of Common Stock	3.47B	150K	-	-	30.49M
Repurchase of Common Stock	-	-	-	-400M	-
Common Dividends Paid	-	-421M	-454M	-1B	-500M
Common & Preferred Stock Dividends Paid	-	-421M	-454M	-1B	-500M
Other Financing Activities, Total	-32.51M	-58M	95.45M	40.15M	-303K
Cash from Financing	3.44B	-487M	-374M	-1.38B	-490M
Foreign Exchange Rate Adjustments	-	-	-	-833K	454K
Net Change in Cash	2.95B	-192M	-124M	-706M	-920M
Supplemental Items
Cash Income Tax Paid (Refund)	86.19M	196M	295M	417M	558M
Levered Free Cash Flow	276M	627M	727M	1.28B	1.19B
Unlevered Free Cash Flow	276M	628M	729M	1.29B	1.19B
Change In Net Working Capital	-2.62M	9.87M	-965K	33.83M	-48.59M
Net Debt Issued / Repaid	-	-8.75M	-15.27M	-15.46M	-20.42M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	10.94	12.96	14.83	19.59	17.64
Return on Total Capital	11.32	13.35	15.43	20.47	18.44
Return On Equity %	16.69	20.03	23.1	29.84	27.11
Return on Common Equity	16.94	20.03	23.24	30.48	27.68
Margin Analysis
Gross Profit Margin %	92.17	93.7	94.85	95.09	94.64
SG&A Margin	16.5	15.28	14.86	14.1	13.21
EBITDA Margin %	67.83	71.62	71.24	72.58	71.79
EBITA Margin %	66.35	70.91	70.58	71.84	70.94
EBIT Margin %	66.32	70.89	70.57	71.6	70.84
Income From Continuing Operations Margin %	61.1	66.12	65.38	64.65	64.66
Net Income Margin %	62	66.15	65.17	64.77	64.7
Net Avail. For Common Margin %	62	66.15	65.17	64.77	64.7
Normalized Net Income Margin	44.91	47.27	46.34	46.91	46.33
Levered Free Cash Flow Margin	38.85	43.3	37.5	44.77	39.25
Unlevered Free Cash Flow Margin	38.85	43.4	37.6	44.82	39.3
Asset Turnover
Asset Turnover	0.26	0.29	0.34	0.44	0.4
Fixed Assets Turnover	4.83	8.69	8.64	10.62	7.53
Receivables Turnover (Average Receivables)	31.84	28.34	19.38	17.19	16.16
Inventory Turnover (Average Inventory)	2.22	2.96	2.45	2.92	2.65
Short Term Liquidity
Current Ratio	49.05	21.3	18.44	14.28	14.67
Quick Ratio	48.68	20.81	18.09	13.96	14.29
Operating Cash Flow to Current Liabilities	4.77	5.28	5.33	6.56	5.6
Days Sales Outstanding (Average Receivables)	11.5	12.88	18.84	21.23	22.65
Days Outstanding Inventory (Average Inventory)	165.1	123.44	149.14	125.09	138.32
Average Days Payable Outstanding	37.16	24.06	45.56	81.25	126.1
Cash Conversion Cycle (Average Days)	139.43	112.25	122.42	65.07	34.87
Long Term Solvency
Total Debt/Equity	-	0.96	1	0.81	0.57
Total Debt / Total Capital	-	0.95	0.99	0.8	0.56
LT Debt/Equity	-	0.8	0.81	0.58	0.33
Long-Term Debt / Total Capital	-	0.79	0.81	0.57	0.33
Total Liabilities / Total Assets	2.19	4.47	5	5.36	4.68
EBIT / Interest Expense	-	480.75	434.68	861.8	840.74
EBITDA / Interest Expense	-	489.34	442.86	880.09	857.91
(EBITDA - Capex) / Interest Expense	-	478.56	393.4	853.37	764.08
Total Debt / EBITDA	-	0.05	0.04	0.03	0.02
Net Debt / EBITDA	-8.93	-3.43	-2.77	-1.85	-2.15
Total Debt / (EBITDA - Capex)	-	0.05	0.05	0.03	0.02
Net Debt / (EBITDA - Capex)	-9.57	-3.51	-3.12	-1.91	-2.41
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	27.18	104.13	33.91	47.99	5.45
Gross Profit, 1 Yr. Growth %	26.55	108.34	35.56	48.38	4.94
EBITDA, 1 Yr. Growth %	37.94	115.03	33.17	51.01	4.25
EBITA, 1 Yr. Growth %	38.78	117.63	33.25	50.89	4.08
EBIT, 1 Yr. Growth %	38.87	117.81	33.3	50.47	4.34
Earnings From Cont. Operations, 1 Yr. Growth %	45.45	120.89	32.38	46.33	5.47
Net Income, 1 Yr. Growth %	43.93	117.81	31.9	47.08	5.33
Normalized Net Income, 1 Yr. Growth %	41.77	114.86	31.28	49.81	4.28
Diluted EPS Before Extra, 1 Yr. Growth %	33.04	76.81	31.83	47.26	5.69
Accounts Receivable, 1 Yr. Growth %	102.36	142.62	76.58	61.3	-18.25
Inventory, 1 Yr. Growth %	15.08	30.34	33.72	6.54	46.36
Net Property, Plant and Equip., 1 Yr. Growth %	-5.16	33.3	35.53	9.28	84.77
Total Assets, 1 Yr. Growth %	522.97	13.65	18.71	9.49	21.72
Tangible Book Value, 1 Yr. Growth %	597.77	10.92	9.31	9.18	23.72
Common Equity, 1 Yr. Growth %	588.05	10.93	16.24	8.58	22.83
Cash From Operations, 1 Yr. Growth %	37.44	121.48	26.64	63.67	-1.38
Capital Expenditures, 1 Yr. Growth %	-1.5	-28.27	575.98	-59.1	275.69
Levered Free Cash Flow, 1 Yr. Growth %	50.31	126.62	15.96	77.13	-4.04
Unlevered Free Cash Flow, 1 Yr. Growth %	50.31	127.11	16.03	76.85	-4.02
Dividend Per Share, 1 Yr. Growth %	-	8	33.33	48.96	27.55
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	48.65	61.12	65.33	40.78	24.92
Gross Profit, 2 Yr. CAGR %	51.17	62.05	68.05	41.82	24.79
EBITDA, 2 Yr. CAGR %	80.92	72.43	69.25	41.69	25.5
EBITA, 2 Yr. CAGR %	83.84	74	70.32	41.68	25.35
EBIT, 2 Yr. CAGR %	83.94	74.08	70.39	41.47	25.3
Earnings From Cont. Operations, 2 Yr. CAGR %	93.18	79.24	71.02	39.18	24.23
Net Income, 2 Yr. CAGR %	89.19	77.06	69.51	39.28	24.47
Normalized Net Income, 2 Yr. CAGR %	82.95	74.53	67.95	40.24	24.92
Diluted EPS Before Extra, 2 Yr. CAGR %	81.43	53.37	52.67	39.33	24.83
Accounts Receivable, 2 Yr. CAGR %	80.87	121.57	106.98	68.76	14.83
Inventory, 2 Yr. CAGR %	43.78	22.47	32.02	19.36	24.87
Net Property, Plant and Equip., 2 Yr. CAGR %	1.18	12.44	34.41	21.7	42.1
Total Assets, 2 Yr. CAGR %	216.11	166.08	16.23	14.01	15.44
Tangible Book Value, 2 Yr. CAGR %	240.78	178.21	10.11	9.24	16.22
Common Equity, 2 Yr. CAGR %	237.34	176.27	13.55	12.34	15.49
Cash From Operations, 2 Yr. CAGR %	77.25	74.47	67.48	43.97	27.05
Capital Expenditures, 2 Yr. CAGR %	-9.45	-15.94	120.21	66.28	23.97
Levered Free Cash Flow, 2 Yr. CAGR %	132.33	84.92	62.11	43.14	27.97
Unlevered Free Cash Flow, 2 Yr. CAGR %	132.09	85.12	62.33	43.07	27.88
Dividend Per Share, 2 Yr. CAGR %	-	-	20	40.93	37.84
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	47.18	65.22	51.49	59.34	27.85
Gross Profit, 3 Yr. CAGR %	50.53	68.01	52.69	61.22	28.28
EBITDA, 3 Yr. CAGR %	72.33	91.8	58.22	62.85	27.94
EBITA, 3 Yr. CAGR %	72.44	94.63	59.21	63.49	27.86
EBIT, 3 Yr. CAGR %	72.54	94.72	59.26	63.36	27.82
Earnings From Cont. Operations, 3 Yr. CAGR %	78.09	102.01	62.03	62.36	26.89
Net Income, 3 Yr. CAGR %	74.9	98.29	60.52	61.68	26.9
Normalized Net Income, 3 Yr. CAGR %	69.97	93.02	58.72	61.67	27
Diluted EPS Before Extra, 3 Yr. CAGR %	70.5	79.88	45.82	50.84	27.12
Accounts Receivable, 3 Yr. CAGR %	89.27	99.48	105.43	90.47	32.54
Inventory, 3 Yr. CAGR %	15.2	39.15	26.11	22.91	27.75
Net Property, Plant and Equip., 3 Yr. CAGR %	3.1	10.92	19.66	25.45	39.87
Total Assets, 3 Yr. CAGR %	126.93	124.77	103.41	13.94	16.52
Tangible Book Value, 3 Yr. CAGR %	142.8	134.42	103.77	9.8	13.87
Common Equity, 3 Yr. CAGR %	140.71	132.84	107.02	11.87	15.74
Cash From Operations, 3 Yr. CAGR %	71.66	90.91	56.8	66.2	26.91
Capital Expenditures, 3 Yr. CAGR %	-8.99	-16.22	68.41	25.64	118.2
Levered Free Cash Flow, 3 Yr. CAGR %	122.26	130.71	58.28	66.83	23.73
Unlevered Free Cash Flow, 3 Yr. CAGR %	122.12	130.72	58.43	66.89	23.7
Dividend Per Share, 3 Yr. CAGR %	-	-	-	28.97	36.32
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	44.7	59.39	54.19	54.97	40.24
Gross Profit, 5 Yr. CAGR %	45.2	61.83	57.18	57	40.85
EBITDA, 5 Yr. CAGR %	79.25	76.1	71.17	69.93	44.17
EBITA, 5 Yr. CAGR %	79.43	76.45	71.67	71.43	44.64
EBIT, 5 Yr. CAGR %	79.7	76.58	71.74	71.36	44.63
Earnings From Cont. Operations, 5 Yr. CAGR %	89.68	78.31	75.23	74.05	45.7
Net Income, 5 Yr. CAGR %	90.23	78.15	72.72	72.17	44.99
Normalized Net Income, 5 Yr. CAGR %	79.72	77.33	69.16	69.87	44.22
Diluted EPS Before Extra, 5 Yr. CAGR %	24.62	66.78	63.13	62.41	37.03
Accounts Receivable, 5 Yr. CAGR %	49.45	68.99	96.17	86.57	62.78
Inventory, 5 Yr. CAGR %	29.91	16.82	21.66	30.87	25.61
Net Property, Plant and Equip., 5 Yr. CAGR %	47.91	17.92	14.64	15.11	28.18
Total Assets, 5 Yr. CAGR %	93.08	75.76	73.65	71.37	62.17
Tangible Book Value, 5 Yr. CAGR %	99.6	81.9	76.96	72.72	62.78
Common Equity, 5 Yr. CAGR %	97.3	80.45	78.23	73.96	63.91
Cash From Operations, 5 Yr. CAGR %	54.51	76.53	69.97	70.53	44.14
Capital Expenditures, 5 Yr. CAGR %	22.57	-15.77	29.59	10.21	48.98
Levered Free Cash Flow, 5 Yr. CAGR %	112.22	302.36	96.05	90.61	45.31
Unlevered Free Cash Flow, 5 Yr. CAGR %	112.22	302.39	96.09	90.57	45.34